Explore the potential of experimental drug NU-9 in early Alzheimer's intervention, targeting toxic amyloid beta forms.
Explore the role of patient-derived biology in enhancing antibody-drug conjugates for more effective cancer treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback